- Home
- TWST vs PACS Comparison
TWST vs PACS Comparison
Compare TWST & PACS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWST
- PACS
- Stock Information
- Founded
- TWST 2013
- PACS 2013
- Country
- TWST United States
- PACS United States
- Employees
- TWST N/A
- PACS N/A
- Industry
- TWST Biotechnology: Biological Products (No Diagnostic Substances)
- PACS
- Sector
- TWST Health Care
- PACS
- Exchange
- TWST Nasdaq
- PACS Nasdaq
- Market Cap
- TWST 2.3B
- PACS 2.1B
- IPO Year
- TWST 2018
- PACS 2024
- Fundamental
- Price
- TWST $31.17
- PACS $12.40
- Analyst Decision
- TWST Buy
- PACS Buy
- Analyst Count
- TWST 9
- PACS 4
- Target Price
- TWST $48.56
- PACS $26.25
- AVG Volume (30 Days)
- TWST 1.9M
- PACS 764.3K
- Earning Date
- TWST 11-17-2025
- PACS 11-06-2025
- Dividend Yield
- TWST N/A
- PACS N/A
- EPS Growth
- TWST N/A
- PACS 82.80
- EPS
- TWST N/A
- PACS 0.68
- Revenue
- TWST $362,273,000.00
- PACS $3,558,953,000.00
- Revenue This Year
- TWST $22.11
- PACS $28.62
- Revenue Next Year
- TWST $17.50
- PACS $16.94
- P/E Ratio
- TWST N/A
- PACS $18.18
- Revenue Growth
- TWST 22.72
- PACS 205.08
- 52 Week Low
- TWST $24.07
- PACS $7.50
- 52 Week High
- TWST $55.33
- PACS $43.92
- Technical
- Relative Strength Index (RSI)
- TWST 52.99
- PACS 48.25
- Support Level
- TWST $28.12
- PACS $12.00
- Resistance Level
- TWST $34.12
- PACS $12.92
- Average True Range (ATR)
- TWST 2.60
- PACS 0.69
- MACD
- TWST 0.09
- PACS -0.16
- Stochastic Oscillator
- TWST 50.79
- PACS 14.55
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
About PACS PACS Group Inc. Common Stock
PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.